# Opportunistic Fungi in Cancer and Hematopoietic Stem-Cell Transplant Patients: Diagnosis and Management Strategies
 You are at:
Online test available
Therapeutic Strategies: Prevention of Fungal Infections
Table of Contents Next CME main Next 

previous  Previous Next  Next

Therapeutic Strategies: Prevention of Fungal Infections

Strategies to prevent or reduce fungal infection: The problems associated with diagnosis and treatment of IFI in oncology patients provide the rationale for using preventative strategies. Evidence-based recommendations for preventing exposure to and disease caused by microbial pathogens, including fungi, are detailed in recent joint publications by the Centers for Disease Control and Prevention, the Infectious Diseases Society of America, and the American Society of Blood and Bone Marrow Transplantation.57,58 Effective prevention of fungal infection is aimed at reducing exposure to fungi, using prophylactic antifungal agents and enhancing the patient's host defenses (Table 5).

Table 5

Reduce Exposure to Organisms
Avoid areas of construction or renovationa
Rooms with HEPA filtrationa
Positive air pressure in rooms relative to corridor air pressure
Hand washing
Decontamination or disinfection of food
Avoid food likely to be contaminated with fungi
Avoid water from hospital water system
Avoid high-exposure activities (gardening, construction)
Suppress Growth of Colonizing Organisms
Amphotericin B
Enhance Host Defenses Against Infection
Hematopoietic growth factors (G-CSF, GM-CSF)
Prevent GVHDa
Reduce immunosuppressive drugsa
Use less mucositis producing agentsa
Optimize number of stem cells in hematopoietic grafta

aRisk factors for infection in multivariable models.
bDecreased infection in randomized trials.

previous  Previous Next  Next

• •   You are at:
Therapeutic Strategies: Prevention of Fungal Infections
   Environmental Issues
   Choice of Antifungal Agent
   Resistance Concerns
   Enhancing Host Defenses

Back to Contents

Course Number: V035D

This CME Expires on July 1, 2005; no tests will be accepted after this date.

This course is accredited by The University of Pittsburgh School of Medicine, Center for Continuing Education and The International Immunocompromised Host Society

  Privacy Policy
Site Contents Copyright © 2006